Cost and Outcome of Intensive Care for Patients With AIDS, Pneumocystis carinii Pneumonia, and Severe Respiratory Failure

JAMA: The Journal of the American Medical Association

Volumn 273, Issue 3, 1995, Pages 230-235

  Wachter, Robert M ^a   Luce, John M ^a   Safrin, Sharon ^a   Berrios, Daniel C ^b   Charlebois, Edwin ^c   Scitovsky, Anne A ^d  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

^b Laboratory Medicine   (United States)

^c UCSF Dept Epidemiol Biostatist   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; COTRIMOXAZOLE; PENTAMIDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; ARTIFICIAL VENTILATION; COST EFFECTIVENESS ANALYSIS; FEMALE; HOSPITAL COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTIS PNEUMONIA; PNEUMOTHORAX; PRIORITY JOURNAL; RESPIRATORY FAILURE; SURVIVAL; TREATMENT OUTCOME;

EID: 84889389756     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1995.03520270064033     Document Type: Article

References (73)

1. Jacobson LP, Kirby AJ, Polk S, et al. Changes in survival after acquired immunodeficiency syndrome(AIDS): 1984-1991. Am J Epidemiol. 1993; 138:952-964.
2. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A. Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. JAMA. 1994;271:1083-1087.
3. Peters BS, Beck EJ, Coleman DG, et al. Changing disease patterns in patients with AIDS in a referral centre in the United Kingdom: the changing face of AIDS. BMJ. 1991;302:203-207.
4. Harris JE. Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984 through 1987. JAMA. 1990; 263:397-401.
5. Dohn MN, Baughman RP, Vigdorth EM, Frame DL. Equal survival rates for first, second, and third episodes of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. Arch Intern Med. 1992;152:2465-2470.
6. Hopewell PC. Pneumocystis carinii pneumonia: diagnosis. J Infect Dis. 1988;157:1115-1119.
7. Bennett CL, Guze PA, Garfinkle JB, Kanouse DE, Greenfield S. The relation between resource use and in-hospital mortality for patients with acquired immunodeficiency syndrome-related Pneumocystis carinii pneumonia. Arch Intern Med. 1990; 150:1447-1452.
8. Tucker KJ, Anton B, Tucker HJ. The effect of human immunodeficiency virus infection on the distribution and outcome of pneumonia in intensive care units. West J Med. 1992;157:637-640.
9. Wachter RM, Luce JM, Turner J, Volberding P, Hopewell PC. Intensive care of patients with the acquired immunodeficiency syndrome: outcome and changing patterns of utilization. Am Rev Respir Dis. 1986;134:891-896.
10. Schein RM, Fischl MA, Pitchenik AE, Sprung CL. ICU survival of patients with the acquired immunodeficiency syndrome. Crit Care Med. 1986; 14:1026-1027.
11. Rosen MJ, Cucco RA, Teirstein AS. Outcome of intensive care in patients with the acquired immunodeficiency syndrome. J Int Care Med. 1986;1:55-60.
12. Rogers PL, Lane HC, Henderson DK, Parrillo J, Masur H. Admission of AIDS patients to a medical intensive care unit: causes and outcome. Crit Care Med. 1989;17:113-117.
13. Murray JF, Felton CP, Garay SM, et al. Pulmonary complications of the acquired immunodeficiency syndrome. N Engl J Med. 1984;310:1682-1688.
14. Stover DE, White DA, Romano PA, Gellene RA, Robeson WA. Spectrum of pulmonary diseases associated with the acquired immune deficiency syndrome. Am J Med. 1985;78:429-437.
15. Garay S. Respiratory failure in AIDS. Am Rev Respir Dis. 1986;133:A344. Abstract.
16. Baggott LA, Baggott BB. Pneumocystis carinii pneumonia in AIDS patients in intensive care. Chest. 1987;92(suppl):132S.
17. Steinbrook R, Lo B, Moulton J, Saika G, Hollander H, Volberding PA. Preferences of homosexual men with AIDS for life-sustaining treatment. N Engl J Med. 1986;314:457-460.
18. Wachter RM, Cooke M, Hopewell PC, Luce JM. Attitudes of medical residents regarding intensive care for patients with the acquired immunodeficiency syndrome. Arch Intern Med. 1988;148:149-152.
19. Bennett RL, Gilman SC, George L, Guze PA, Bennett CL. Improved outcomes in intensive care units for AIDS-related Pneumocystis carinii pneumonia: 1987-1991. J Acquir Immune Defic Syndr. 1993;6:1319-21.
20. Curtis JR, Greenberg DL, Hudson LD, Fisher LD, Krone MR, Collier AC. Changing use of intensive care for HIV-infected patients with Pneumocystis carinii pneumonia. Am Rev Respir Dis. 1994;150:1305-1310.
21. Friedman Y, Franklin C, Freels S, Weil MH. Long-term survival of patients with AIDS, pneumocystis carinii pneumonia, and respiratory failure. JAMA. 1991;266:89-92.
22. Wachter RM, Russi MB, Hopewell PC, Luce JM. Pneumocystis carinii pneumonia and respiratory failure in AIDS: improved outcomes and increased use of intensive care units. Am Rev Respir Dis. 1991;143:251-256.
23. El-Sadr W, Simberkoff MS. Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation. Am Rev Respir Dis. 1988;137:1264-1267.
24. Montaner JS, Russell JA, Lawson L, Ruedy J. Acute respiratory failure secondary to Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a potential role for systemic corticosteroids. Chest. 1989;95:881-884.
25. Friedman Y, Franklin C, Rackow EC, Weil MH. Improved survival in patients with acquired immunodeficiency syndrome, Pneumocystis carinii pneumonia, and severe respiratory failure. Chest. 1989;96:862-866.
26. Efferen LS, Nadarajah D, Palat DS. Survival following mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: a different perspective. Am J Med. 1989;87:401-404.
27. Bozzette SA, Feigal D, Chiu J, Gluckstein D, Kemper C, Sattler F. Length of stay and survival after intensive care for severe Pneumocystis carinii pneumonia: a prospective study, California Collaborative Treatment Group. Chest. 1992;101: 1404-1406.
28. Gachot B, Clair B, Wolff M, Regnier B, Vachon F. Continuous positive airway pressure by face mask or mechanical ventilation in patients with human immunodeficiency virus infection and severe Pneumocystis carinii pneumonia. Intensive Care Med. 1992;18:155-159.
29. Montaner JS, Hawley PH, Ronco JJ, et al. Multisystem organ failure predicts mortality of ICU patients with acute respiratory failure secondary to AIDS-related PCP. Chest. 1992;102:1823-1828.
30. Peruzzi WT, Skoutelis A, Shapiro BA, et al. Intensive care unit patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia: suggested predictors of hospital outcome. Crit Care Med. 1991;19:892-900.
31. Wachter RM, Luce JM, Hopewell PC. Critical care of patients with AIDS. JAMA. 1992;267:541-547.
32. Oye RK, Bellamy PE. Patterns of resource consumption in medical intensive care. Chest. 1991;99: 685-689.
33. Sonnefield ST, Waldo DR, Lemieux JA, McKusick DR. Projections of national health expenditures through the year 2000. Health Care Financ Rev. 1991;13:1-27.
34. Engelhardt HT Jr, Rie MA. Intensive care units, scarce resources, and conflicting principles of justice. JAMA. 1986;255:1159-1164.
35. Strauss MJ, LoGerfo JP, Yeltatzie JA, Temkin N, Hudson LD. Rationing of intensive care unit services: an everyday occurrence. JAMA. 1986;255: 1143-1146.
36. Levine ME. Ration or rescue: the elderly patient in critical care. Crit Care Nurs Q. 1989;12:82-89.
37. Bone RC, Elpern EH. Honoring patient preferences and rationing intensive care: are these compatible goals? Arch Intern Med. 1991;151:1061-1063.
38. Hellinger FJ. The lifetime cost of treating a person with HIV. JAMA. 1993;270:474-478.
39. Udvarhelyi IS, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analysis in the medical literature: are the methods being used correctly? Ann Intern Med. 1992;116:238-244.
40. Welch HG, Larson EB. Cost effectiveness of bone marrow transplantation in acute nonlymphocytic leukemia. N Engl J Med. 1989;321:807-812.
41. Clement M, Edison R, Turner J, et al. Corticosteroids as adjunctive therapy in severe Pneumocystis carinii pneumonia: a prospective placebo-controlled trial. Am Rev Respir Dis. 1989;139:A250. Abstract.
42. Bozzette SA, Sattler FR, Chui J, et al. A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med. 1990;323:1451-1457.
43. Gagnon S, Boota AM, Fischl MA, Baier H, Kirksey OW, La Voie L. Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a double-blind, placebo-controlled trial. N Engl J Med. 1990;323:1444-1450.
44. Montaner JSG, Lawson LM, Levitt N, Belzberg A, Schecter MT, Ruedy J. Corticosteroids prevent early deterioration in patients with moderately severe Pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome(AIDS). Ann Intern Med. 1990;113:14-20.
45. Eddy DM. Comparing benefits and harms: the balance sheet. JAMA. 1990;263:2493-2505.
46. Hadorn DC. Setting health care priorities in Oregon: cost-effectiveness meets the rule of rescue. JAMA. 1991;265:2218-2225.
47. Callahan D. Evaluating the Oregon priority plan. J Am Geriatr Soc. 1991;39:622-623.
48. Daniels N. Is the Oregon rationing plan fair? JAMA. 1991;265:2232-2235.
49. Pear R. US backs Oregon's health plan for covering all poor people. New York Times. March 20, 1993:11.
50. Oregon Health Services Commission. Prioritization of Health Services: A Report to the Governor and Legislature. Salem: Oregon Health Service Commission; 1991.
51. Goldman L, Gordon DJ, Rifkind BM, et al. Cost and health implications of cholesterol lowering. Circulation. 1992;85:1960-1968.
52. Schapira DV, Studnicki J, Bradham DD, Wolff P, Jarrett A. Intensive care, survival, and expense of treating critically ill cancer patients. JAMA. 1993; 269:783-786.
53. Mandelblatt JS, Fahs MC. The cost-effectiveness of cervical cancer screening for low-income elderly women. JAMA. 1988;259:2409-2413.
54. Edelson JT, Weinstein MC, Tosteson ANA, Williams L, Lee TH, Goldman L. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA. 1990;263: 407-413.
55. Freedberg KA, Tosteson AN, Cohen CJ, Cotton DJ. Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis. J Acquir Immune Defic Syndr. 1991;4:521-531.
56. Schulman KA, Lynn LA, Glick HA, et al. Cost effectiveness of low-dose zidovudine therapy for asymptomatic patients with human immunodeficiency virus(HIV)infection. Ann Intern Med. 1991; 114:798-802.
57. Kinosian BP, Eisenberg JM. Cutting into cholesterol: cost-effective alternatives for treating hypercholesterolemia. JAMA. 1988;259:2249-2254.
58. Bennett CL, Cvitanic M, Pascal A. The costs of AIDS in Los Angeles. J Acquir Immune Defic Syndr. 1991;4:197-203.
59. Hardy AM, Rauch K, Echenberg D, Morgan WM, Curran JW. The economic impact of the first 10 000 cases of acquired immunodeficiency syndrome in the United States. JAMA. 1986;255:209-211.
60. Scitovsky AA, Cline M, Lee P. Medical care costs of patients with AIDS in San Francisco. JAMA. 1986;256:3103-3106.
61. Wachter RM, Luce JM, Hearst N, Lo B. Decisions about resuscitation: inequities among patients with different diseases but similar prognoses. Ann Intern Med. 1989;111:525-532.
62. Scitovsky AA. Studying the cost of HIV-related illness: reflections on the moving target. Milbank Q. 1989;67:318-324.
63. Staikowsky F, Lafon B, Guidet B, Denis M, Mayaud C, Offenstadt G. Mechanical ventilation for Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: is the prognosis really improved? Chest. 1993;104:756-762.
64. Hawley PH, Ronco JJ, Guillemi SA, et al. Decreasing frequency but worsening mortality of acute respiratory failure secondary to AIDS-related Pneumocystis carinii pneumonia. Chest. 1994;106:1456-1459.
65. Yarchoan R, Venzon DJ, Pluda JM, et al. CD4 count and the risk for death in patients infected with HIV receiving antiretroviral therapy. Ann Intern Med. 1991;115:184-189.
66. Tobin MJ. Mechanical ventilation. N Engl J Med. 1994;330:1056-1061.
67. Smith RL, Levine SM, Lewis ML. Prognosis of patients with AIDS requiring intensive care. Chest. 1989;96:857-861.
68. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE-II: a severity of disease classification system for acutely ill patients. Crit Care Med. 1985;13:818-829.
69. Angell M. Cost containment and the physician. JAMA. 1985;254:1203-1207.
70. Levinsky NG. The doctor's master. N Engl J Med. 1984;311:1573-1575.
71. Relman AS. The trouble with rationing. N Engl J Med. 1990;323:911-913.
72. Stein M, O'Sullivan P, Wachtel T, et al. Causes of death in persons with human immunodeficiency virus infection. Am J Med. 1992;93:387-390.
73. Levinsky NG. The organization of medical care: lessons from the Medicare End Stage Renal Disease Program. N Engl J Med. 1993;329:1395-1399.